Aquatic Capital Management Boosts ResMed Stake by 106%

Institutional investor adds over 12,600 shares of medical equipment provider in Q3

Mar. 16, 2026 at 7:23am

Got story updates? Submit your updates here. ›

Aquatic Capital Management LLC increased its stake in ResMed Inc. (NYSE:RMD) by 106% in the third quarter, according to a recent 13F filing with the Securities and Exchange Commission. The institutional investor now owns 24,564 shares of the medical equipment provider's stock, worth approximately $6.7 million.

Why it matters

ResMed is a leading global provider of medical devices and cloud-connected solutions for sleep apnea and other respiratory conditions. The company's products are widely used by patients, clinicians, and healthcare providers worldwide. Aquatic Capital Management's increased investment in ResMed signals the firm's confidence in the company's growth potential and market position.

The details

According to the 13F filing, Aquatic Capital Management acquired an additional 12,642 shares of ResMed during the third quarter, bringing its total holdings to 24,564 shares. ResMed's stock price has fluctuated in recent months, trading between $199.92 and $293.81 over the past 52 weeks.

  • Aquatic Capital Management filed its 13F report for the third quarter of 2026.

The players

Aquatic Capital Management LLC

An institutional investor that manages a portfolio of stocks, including a significant position in medical equipment provider ResMed Inc.

ResMed Inc.

A global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

Aquatic Capital Management's increased investment in ResMed suggests the firm sees strong growth potential in the medical equipment provider's business, which is focused on addressing the growing prevalence of sleep apnea and other respiratory conditions worldwide.